Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
210M
-
Number of holders
-
87
-
Total 13F shares, excl. options
-
53.7M
-
Shares change
-
+1.84M
-
Total reported value, excl. options
-
$652M
-
Value change
-
+$25.6M
-
Put/Call ratio
-
0.94
-
Number of buys
-
45
-
Number of sells
-
-46
-
Price
-
$12.16
Significant Holders of BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) as of Q4 2014
120 filings reported holding BCRX - BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share as of Q4 2014.
BIOCRYST PHARMACEUTICALS INC - Common Stock, $0.01 par value per share (BCRX) has 87 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 53.7M shares
of 210M outstanding shares and own 25.6% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (10.7M shares), FMR LLC (10.4M shares), WELLINGTON MANAGEMENT GROUP LLP (7.39M shares), BlackRock Fund Advisors (2.8M shares), State Street Corp (2.79M shares), VANGUARD GROUP INC (2.28M shares), RTW INVESTMENTS, LLC (2.26M shares), BlackRock Institutional Trust Company, N.A. (1.91M shares), VHCP Management, LLC (1.74M shares), and D. E. Shaw & Co., Inc. (1.67M shares).
This table shows the top 87 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.